2023
DOI: 10.3390/ijms24054881
|View full text |Cite
|
Sign up to set email alerts
|

Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection

Abstract: Despite the diversity of liquid biopsy transcriptomic repertoire, numerous studies often exploit only a single RNA type signature for diagnostic biomarker potential. This frequently results in insufficient sensitivity and specificity necessary to reach diagnostic utility. Combinatorial biomarker approaches may offer a more reliable diagnosis. Here, we investigated the synergistic contributions of circRNA and mRNA signatures derived from blood platelets as biomarkers for lung cancer detection. We developed a co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 47 publications
2
1
0
Order By: Relevance
“…5c ). Similar to previous work assessing circRNAs as a lung cancer biomarker 94 , combining circRNA expression with gene expression showed a small improvement in predictive ability over gene expression alone in both PPMI (AUC = 0.85 vs 0.84, Fig. 5c ) and ICICLE-PD (AUC = 0.60 vs 0.59, Fig.…”
Section: Discussionsupporting
confidence: 83%
“…5c ). Similar to previous work assessing circRNAs as a lung cancer biomarker 94 , combining circRNA expression with gene expression showed a small improvement in predictive ability over gene expression alone in both PPMI (AUC = 0.85 vs 0.84, Fig. 5c ) and ICICLE-PD (AUC = 0.60 vs 0.59, Fig.…”
Section: Discussionsupporting
confidence: 83%
“…5c). Similar to previous work assessing circRNAs as a lung cancer biomarker 90 , combining circRNA expression with gene expression showed a small improvement in predictive ability over gene expression alone in both PPMI (AUC = 0.85 vs 0.84, Fig. 5c) and ICICLE-PD (AUC = 0.60 vs 0.59, Fig.…”
Section: Discussionsupporting
confidence: 83%
“…Notably, the study involved four seasoned thoracic radiologists, demonstrating a comprehensive and expert-driven evaluation of the recommended approach. In [5], Silvia D'Ambrosi et al gave a presentation on a study that described a combinatory signature of circRNA and mRNA derived from blood platelets for the early identification of lung cancer. Researchers used a computational framework that leverages nCounter analysis of data and machine learning to investigate platelet mRNA and circRNA for the diagnosis of lung cancer.…”
Section: Literature Reviewmentioning
confidence: 99%